{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:18:01Z","timestamp":1773227881678,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ejogrb.2011.02.026","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T15:11:12Z","timestamp":1301065872000},"page":"38-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Is testing for aspirin response worthwhile in high-risk pregnancy?"],"prefix":"10.1016","volume":"157","author":[{"given":"Evelyne","family":"Rey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges-E.","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2011.02.026_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0015","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0020","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajog.2010.01.050","article-title":"An international trial of antioxidants in the prevention of preeclampsia (INTAPP)","volume":"202","author":"Xu","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0030","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/bmj.38043.583160.EE","article-title":"Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands","volume":"328","author":"Evers","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","article-title":"Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study","volume":"51","author":"Chappell","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ajog.2003.11.031","article-title":"Is early-pregnancy proteinuria associated with an increased rate of preeclampsia in women with pregestational diabetes mellitus?","volume":"190","author":"How","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2337\/dc09-1219","article-title":"Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study","volume":"33","author":"Jensen","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0050","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S1701-2163(16)34023-3","article-title":"Maternal obesity and the risk of placental vascular disease","volume":"30","author":"Becker","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199809033391004","article-title":"Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"339","author":"Sibai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0065","first-page":"551","article-title":"Low-dose aspirin in pregnancy","volume":"74","author":"Sibai","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0090-6980(96)00024-X","article-title":"Dose-related effects of low dose aspirin on hemostasis parameters and prostacyclin\/thromboxane ratios in late pregnancy","volume":"51","author":"Martin","year":"1996","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0075","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S1807-59322005000500010","article-title":"Prevention of preeclampsia with low-dose aspirin\u2014a systematic review and meta-analysis of the main randomized controlled trials","volume":"60","author":"Ruano","year":"2005","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9378(98)70130-9","article-title":"Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units","volume":"179","author":"Hauth","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0090","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0002-9378(95)90285-6","article-title":"Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial","volume":"173","author":"Hauth","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9378(99)70163-8","article-title":"Effect of aspirin in pregnant women is dependent on increase in bleeding time","volume":"180","author":"Dumont","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.96.1.69","article-title":"Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease","volume":"96","author":"Davi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0105","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/j.thromres.2010.03.013","article-title":"Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus","volume":"126","author":"Mortensen","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1751-7141.2009.00058.x","article-title":"Effect of obesity on platelet reactivity and response to low-dose aspirin","volume":"13","author":"Bordeaux","year":"2010","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0120","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2006.01771.x","article-title":"Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function","volume":"4","author":"Hayward","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0130","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1538-7836.2008.03184.x","article-title":"Aspirin \u2018resistance\u2019: role of pre-existent platelet reactivity and correlation between tests","volume":"6","author":"Frelinger","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0135","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1160\/TH09-08-0527","article-title":"A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease","volume":"103","author":"Grove","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2011.02.026_bib0140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \u201cresistance\u201d","volume":"53","author":"Santilli","year":"2009","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511001382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211511001382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:25:15Z","timestamp":1759555515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211511001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0301211511001382"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.02.026","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is testing for aspirin response worthwhile in high-risk pregnancy?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2011.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}